
Uncovering Fraud in Pharmaceutical R&D and Manufacturing. By popular demand, I will include my art pieces that have nothing to do with Pharma. If you are interested in my art, visit www.sashalatypova.com
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 692 | Founded | 4 years ago | Last Issue | 4 days ago |
| Active | |||||

Today is the day! Rand Paul is going to grill Fauci as part of his ongoing investigation of the “origins of COVID-19” and “the coverup of the gain-of-function research” and other super exciting stuff. Are you going to be glued to your compu...
Here is the source document, i.e. a so-called “personal diary” of Anthony Fauci released by Rand Paul’s Congressional committee, which we discuss in the video below. It is 1141 pages long.
Before we proceed, I am reminded of this famous qu...
As reported by Endpoints news on July 17:
GSK is launching a 33,600-person study to see whether elderly people who get its shingles vaccine Shingrix are less likely to develop any form of dementia, including Alzheimer’s, compared to thos...
I hope that everyone reading my articles is already familiar with the name “SV40”. You have probably witnessed numerous online screaming matches where one side says “simian virus” doesn’t exist, while “genomics experts”...
This post is continuing on the topics of the Cult of Hellth. Part 1 here.
“Animal Farm” got the most important point correctly - as time passes, the “revolutionary” pigs become increasingly corrupt, changing the farm's original rules to be...
Subscribers, engagement, traffic and sponsorship for Due Diligence and Art.
| Subscribers | Engagement | 91 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Where Due Diligence and Art ranks on Google, and how much search traffic it brings in.
| Ranked Keywords | 88 | Monthly Search Traffic | Top Keywords |
|---|
How this newsletter ranks in the official Substack charts.
| #19 | |
| #19 |
The writers behind this newsletter.
I could not become a professional artist, so I became a pharma and medical device R&D executive. If you are interested in my art, visit sashalatypova.com
I could not become a professional artist, so I became a pharma and medical device R&D executive. If you are interested in my art, visit sashalatypova.com
You can find recent issues that have been published by Due Diligence and Art on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Due Diligence and Art, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Due Diligence and Art as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Due Diligence and Art using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Due Diligence and Art. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.